The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Current challenges in non-invasive insulin delivery systems: A comparative review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, A. C., & Barry, B. W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.025 · Cited by 1,746
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
The 500 Dalton rule for the skin penetration of chemical compounds and drugs
Bos, J. D., & Meinardi, M. M. H. M. (2000) · Experimental Dermatology · doi:10.1034/j.1600-0625.2000.009003165.x · Cited by 1,465
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Novel mechanisms and devices to enable successful transdermal drug delivery
Barry, B. W. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00167-1 · Cited by 1,240
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Protein drug stability: a formulation challenge
Frokjaer, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,096
Chitosan-based gastrointestinal delivery systems
Hejazi, R., & Amiji, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00126-3 · Cited by 882
McAllister, D. V., Wang, P. M., Davis, S. P., Park, J.-H., Canatella, P. J., Allen, M. G., & Prausnitz, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331316100 · Cited by 859
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
Kalia, Y. N., Naik, A., Garrison, J., & Guy, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.026 · Cited by 858
Ultrasound-Mediated Transdermal Protein Delivery
Mitragotri, S., Blankschtein, D., & Langer, R. (1995) · Science · doi:10.1126/science.7638603 · Cited by 791
Biomaterials in Drug Delivery and Tissue Engineering: One Laboratory's Experience
Langer, R. (2000) · Accounts of Chemical Research · doi:10.1021/ar9800993 · Cited by 750
Buccal bioadhesive drug delivery — A promising option for orally less efficient drugs
Sudhakar, Y., Kuotsu, K., & Bandyopadhyay, A. K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.012 · Cited by 724
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Ultrasonic drug delivery – a general review
Pitt, W. G., Husseini, G. A., & Staples, B. J. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.37 · Cited by 621
Thiomers: A new generation of mucoadhesive polymers
BERNKOPSCHNURCH, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.002 · Cited by 610
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Ahsan, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00549-1 · Cited by 570
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
Transdermal Delivery of Insulin Using Microneedles in Vivo
Martanto, W., Davis, S. P., Holiday, N. R., Wang, J., Gill, H. S., & Prausnitz, M. R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029282.44140.2e · Cited by 521
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515
Self-citationCevc, G. (1996) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v13.i3-4.30 · Cited by 506
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Mucoadhesive nanoparticulate systems for peptide drug delivery
Takeuchi, H., Yamamoto, H., & Kawashima, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00120-4 · Cited by 488
Microencapsulated chitosan nanoparticles for lung protein delivery
Grenha, A., Seijo, B., & Remuñán-López, C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.009 · Cited by 469
Chitosan and its derivatives in mucosal drug and vaccine delivery
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00172-5 · Cited by 456
Kast, C. E., & Bernkop-Schnürch, A. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00421-x · Cited by 453
Mucoadhesive nanoparticulate systems for peptide drug delivery.
Takéuchi, Hirofumi, Yamamoto, Y., Hiromitsu, Kawashima, & Yoshiaki (2002) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 432
Bernkop-Schnürch, A. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00271-0 · Cited by 426
The lung as a route for systemic delivery of therapeutic proteins and peptides
Uchenna Agu, R., Ikechukwu Ugwoke, M., Armand, M., Kinget, R., & Verbeke, N. (2001) · Respiratory Research · doi:10.1186/rr58 · Cited by 411
Oral delivery of insulin using pH‐responsive complexation gels
Lowman, A. M., Morishita, M., Kajita, M., Nagai, T., & Peppas, N. A. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980337n · Cited by 406
Self-citationMitragotri, S., & Kost, J. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.024 · Cited by 401
Design principles of chemical penetration enhancers for transdermal drug delivery
Karande, P., Jain, A., Ergun, K., Kispersky, V., & Mitragotri, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501176102 · Cited by 399
Mikszta, J. A., Alarcon, J. B., Brittingham, J. M., Sutter, D. E., Pettis, R. J., & Harvey, N. G. (2002) · Nature Medicine · doi:10.1038/nm0402-415 · Cited by 398
Cui, F., Shi, K., Zhang, L., Tao, A., & Kawashima, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.013 · Cited by 391
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
Takeuchi, H., Yamamoto, H., Niwa, T., Hino, T., & Kawashima, Y. (1996) · Pharmaceutical Research · doi:10.1023/a:1016009313548 · Cited by 389
Matriano, J. A., Cormier, M., Johnson, J., Young, W. A., Buttery, M., Nyam, K., & Daddona, P. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1013607400040 · Cited by 373
Peptide and protein drug delivery to and into tumors: challenges and solutions
Torchilin, V. P., & Lukyanov, A. N. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02623-0 · Cited by 363
Evaluation of the clearance characteristics of bioadhesive systems in humans
Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S., & Illum, L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00367-6 · Cited by 360
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
Nasal route and drug delivery systems
Türker, S., Onur, E., & Ózer, Y. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000026823.82950.ff · Cited by 354
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968611962 · Cited by 320
Lectin-mediated drug delivery:
Lehr, C.-M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00228-x · Cited by 308
Roldo, M., Hornof, M., Caliceti, P., & Bernkop‐Schnürch, A. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00157-7 · Cited by 292
Dyer, A. M., Hinchcliffe, M., Watts, P., Castile, J., Jabbal-Gill, I., Nankervis, R., Smith, A., & Illum, L. (2002) · Pharmaceutical Research · doi:10.1023/a:1016418523014 · Cited by 280
Discovery of transdermal penetration enhancers by high-throughput screening
Karande, P., Jain, A., & Mitragotri, S. (2004) · Nature Biotechnology · doi:10.1038/nbt928 · Cited by 280
A multichannel neural probe for selective chemical delivery at the cellular level
Chen, J., Wise, K. D., Hetke, J. F., & Bledsoe, S. C. (1997) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.605435 · Cited by 280
Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine
Bernkop-Schnürch, A., Kast, C. E., & Richter, M. F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00227-9 · Cited by 270
Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects
Skyler, J. S., Weinstock, R. S., Raskin, P., Yale, J.-F., Barrett, E., Gerich, J. E., Gerstein, H. C., & the Inhaled Insulin Phase III Type 1 Diabetes Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1630 · Cited by 269
Fasano, A., & Uzzau, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119271 · Cited by 266
Hollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J.-L., Levin, S. R., & for the Exubera Phase III Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2356 · Cited by 264
Current Status and Future Prospects of Transdermal Drug Delivery
Guy, R. H. (1996) · Pharmaceutical Research · doi:10.1023/a:1016060403438 · Cited by 250
Silicon-processed microneedles
Lin, L., & Pisano, A. P. (1999) · Journal of Microelectromechanical Systems · doi:10.1109/84.749406 · Cited by 250
Transdermal protein delivery by a coadministered peptide identified via phage display
Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., Liu, S., Zhang, M., & Wen, L.-P. (2006) · Nature Biotechnology · doi:10.1038/nbt1193 · Cited by 249
Thomas, B. J., & Finnin, B. C. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03180-0 · Cited by 245
O'Hara, P., & Hickey, A. J. (2000) · Pharmaceutical Research · doi:10.1023/a:1007527204887 · Cited by 242
Micromachined electrodes for biopotential measurements
Griss, P., Enoksson, P., Tolvanen-Laakso, H. K., Merilainen, P., Ollmar, S., & Stemme, G. (2001) · Journal of Microelectromechanical Systems · doi:10.1109/84.911086 · Cited by 239
Quattrin, T., Bélanger, A., Bohannon, N. J. V., Schwartz, S. L., & for the Exubera Phase III Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2622 · Cited by 225
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
Bernkop-Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00136-3 · Cited by 223
Synergistic Effect of Enhancers for Transdermal Drug Delivery
Mitragotri, S. (2000) · Pharmaceutical Research · doi:10.1023/a:1007522114438 · Cited by 219
Tezel, A., & Mitragotri, S. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74770-5 · Cited by 210
New horizons — alternative routes for insulin therapy
Owens, D. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd836 · Cited by 209
Mucoadhesive Microspheres for Controlled Drug Delivery
Chowdary, K. P. R., & Srinivasa Rao, Y. (2004) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.27.1717 · Cited by 198
Morishita, M., Goto, T., Nakamura, K., Lowman, A. M., Takayama, K., & Peppas, N. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.029 · Cited by 191
Self-citationMucoadhesion of colloidal particulate systems in the gastro-intestinal tract
Ponchel, G., Montisci, M.-J., Dembri, A., Durrer, C., & Duchêne, D. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00098-2 · Cited by 191
Morlock, M., Koll, H., Winter, G., & Kissel, T. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(96)00017-3 · Cited by 188
Nakamura, K., Murray, R. J., Joseph, J. I., Peppas, N. A., Morishita, M., & Lowman, A. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.022 · Cited by 188
Self-citationConcept, Strategies, and Feasibility of Noninvasive Insulin Delivery
Cefalu, W. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.239 · Cited by 182
Hinchcliffe, M., & Illum, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00073-8 · Cited by 180
Kawashima, Y., Yamamoto, H., Takeuchi, H., Fujioka, S., & Hino, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00048-6 · Cited by 178
Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats
Krauland, A. H., Guggi, D., & Bernkop-Schnürch, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.017 · Cited by 176
Devices based on intelligent biopolymers for oral protein delivery
Peppas, N. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.03.001 · Cited by 174
Clearance characteristics of chitosan based formulations in the sheep nasal cavity
Soane, R. J., Hinchcliffe, M., Davis, S. S., & Illum, L. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00602-0 · Cited by 172
Pillai, O. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00094-4 · Cited by 172
Comparative, Quantitative Study of Lymphoid and Non-Lymphoid Uptake of 60 nm Polystyrene Particles
Hillery, A., Jani, P., & Florence, A. (1994) · Journal of Drug Targeting · doi:10.3109/10611869409015904 · Cited by 169
Sonophoresis. II. Examination of the Mechanism(s) of Ultrasound-Enhanced Transdermal Drug Delivery
Bommannan, D., Menon, G. K., Okuyama, H., Elias, P. M., & Guy, R. H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015806528336 · Cited by 166
Effect of ultrasound on transdermal drug delivery to rats and guinea pigs.
Levy, D., Kost, J., Meshulam, Y., & Langer, R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114119 · Cited by 164
Pulmonary delivery of insulin by liposomal carriers
Huang, Y.-Y., & Wang, C.-H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.014 · Cited by 164
Transcellular uptake mechanisms of the intestinal epithelial barrier Part one
Daugherty, A. L., & Mrsny, R. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00142-x · Cited by 163
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.006 · Cited by 161
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat
Kisel, M. A., Kulik, L. N., Tsybovsky, I. S., Vlasov, A. P., Vorob'yov, M. S., Kholodova, E. A., & Zabarovskaya, Z. V. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00579-8 · Cited by 161
Development of acrylic-based copolymers for oral insulin delivery
Foss, A. C., Goto, T., Morishita, M., & Peppas, N. A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00145-0 · Cited by 161
Self-citationStabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres
Meinel, L., Illi, O., Zapf, J., Malfanti, M., Merkle, H. P., & Gander, B. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00352-7 · Cited by 160
Surendrakumar, K., Martyn, G. P., Hodgers, E. C. M., Jansen, M., & Blair, J. A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00263-3 · Cited by 160
Suarez, S., O'Hara, P., Kazantseva, M., Newcomer, C. E., Hopfer, R., McMurray, D. N., & Hickey, A. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1013094112861 · Cited by 159
Zhang, Q., Shen, Z., & Nagai, T. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00614-7 · Cited by 159
Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment
Lamprecht, A., Saumet, J.-L., Roux, J., & Benoit, J.-P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.018 · Cited by 158
Rosenstock, J., Zinman, B., Murphy, L. J., Clement, S. C., Moore, P., Bowering, C. K., Hendler, R., Lan, S.-P., & Cefalu, W. T. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-8-200510180-00005 · Cited by 158
Kawashima, Yoshiaki, Yamamoto, Y., Hiromitsu, Takéuchi, Hirofumi, Fujioka, Satoshi, S., Hino, & Tomoaki (2000) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 155
Frequency Dependence of Sonophoresis
Tezel, A., Sens, A., Tuchscherer, J., & Mitragotri, S. (2001) · Pharmaceutical Research · doi:10.1023/a:1013366328457 · Cited by 151
Marschütz, M. K., & Bernkop‐Schnürch, A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00039-9 · Cited by 151
Development of controlled drug release systems based on thiolated polymers
Bernkop‐Schnürch, A., Scholler, S., & Biebel, R. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00256-4 · Cited by 149
Eudragit S100 entrapped insulin microspheres for oral delivery
Jain, D., Panda, A. K., & MAJUMDAR, D. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060116 · Cited by 147
Using microemulsion formulations for oral drug delivery of therapeutic peptides
Sarciaux, J. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00386-j · Cited by 144
Sonophoresis. I. The Use of High-Frequency Ultrasound to Enhance Transdermal Drug Delivery
Bommannan, D. B., Okuyama, H., Stauffer, P. R., & Guy, R. H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015808917491 · Cited by 143
Thiomers: potential excipients for non-invasive peptide delivery systems
Bernkop‐Schnürch, A., Krauland, A. H., Leitner, V. M., & Palmberger, T. F. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.032 · Cited by 143
Uchiyama, T., Sugiyama, T., Quan, Y., Kotani, A., Okada, N., Fujita, T., Muranishi, S., & Yamamoto, A. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991776976 · Cited by 142
MORISHITA, M., Morishita, I., TAKAYAMA, K., Machida, Y., & NAGAI, T. (1993) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.16.68 · Cited by 141
Self-citationMorishita, M., Goto, T., Peppas, N. A., Joseph, J. I., Torjman, M. C., Munsick, C., Nakamura, K., Yamagata, T., Takayama, K., & Lowman, A. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.008 · Cited by 140
Self-citationEfficacy of Inhaled Insulin in Patients With Type 2 Diabetes not Controlled With Diet and Exercise
DeFronzo, R. A., Bergenstal, R. M., Cefalu, W. T., Pullman, J. R., Lerman, S., Bode, B. W., Phillips, L. S., & for the Exubera Phase III Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1922 · Cited by 138
Low-Frequency Sonophoresis: A Noninvasive Method of Drug Delivery and Diagnostics
Mitragotri, S., & Kost, J. (2000) · Biotechnology Progress · doi:10.1021/bp000024+ · Cited by 137
Effect of sonication parameters on transdermal delivery of insulin to hairless rats
Boucaud, A., Garrigue, M. A., Machet, L., Vaillant, L., & Patat, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00054-8 · Cited by 133
Inhaled Insulin Using the AERx Insulin Diabetes Management System in Healthy and Asthmatic Subjects
Henry, R. R., Mudaliar, S. R. D., Howland, W. C., Chu, N. V., Kim, D. S., An, B., & Reinhardt, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.764 · Cited by 133
Synergistic Effects of Chemical Enhancers and Therapeutic Ultrasound on Transdermal Drug Delivery
Johnson, M. E., Mitragotri, S., Patel, A. B., Blankschtein, D., & Langer, R. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960079z · Cited by 131
Morishita, M., Barichello, J. M., Takayama, K., et al. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00615-3 · Cited by 131
Self-citationUngaro, F., Rosa, G. D., Miro, A., Quaglia, F., & Rotonda, M. I. L. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.05.005 · Cited by 127
Thiolated chitosan microparticles: A vehicle for nasal peptide drug delivery
Krauland, A. H., Guggi, D., & Bernkop‐Schnürch, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.016 · Cited by 126
The Impact of Smoking on Inhaled Insulin
Himmelmänn, A., JENDLE, J. H., Mellén, A., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.677 · Cited by 124
Ye, S., Wang, C., Liu, X., Tong, Z., Ren, B., & Zeng, F. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.015 · Cited by 123
Delivery of Bioactive Peptides and Proteins Across Oral (Buccal) Mucosa
Senel, S., Kremer, M. J., Katalin, N., & Squier, C. A. (2001) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201013378734 · Cited by 119
Batheja, P., Thakur, R., & Michniak‐Kohn, B. B. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.1.127 · Cited by 119
Intensive Therapy With Inhaled Insulin via the AERx Insulin Diabetes Management System
Hermansen, K., Rönnemaa, T., Petersen, A. H., Bellaire, S., & Adamson, U. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.162 · Cited by 118
Treatment Satisfaction With Inhaled Insulin in Patients With Type 1 Diabetes
Gerber, R. A., Cappelleri, J. C., KOURIDES, I. A., & Gelfand, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1556 · Cited by 114
Synergistic Effect of Low‐Frequency Ultrasound and Surfactants on Skin Permeability
Tezel, A., Sens, A., Tuchscherer, J., & Mitragotri, S. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10000 · Cited by 112
Drug Delivery by Phonophoresis
Tyle, P., & Agrawala, P. (1989) · Pharmaceutical Research · doi:10.1023/a:1015967012253 · Cited by 111
Design and In Vivo Evaluation of An Oral Delivery System for Insulin
Marschütz, M. K., Caliceti, P., & Bernkop‐Schnürch, A. (2000) · Pharmaceutical Research · doi:10.1023/a:1007696723125 · Cited by 109
Kim, B.-Y., Jeong, J. H., Park, K., & Kim, J.-D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.032 · Cited by 108
Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers
Pillai, O., Nair, V. B., & Panchagnula, R. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.032 · Cited by 108
Wang, J., Tabata, Y., & Morimoto, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.011 · Cited by 105
Physical enhancement of dermatologic drug delivery: Iontophoresis and phonophoresis
Kassan, D. G., Lynch, A. M., & Stiller, M. J. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)80069-7 · Cited by 104
Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients
Brunner, G. A., Balent, B., Ellmerer, M., et al. (2001) · Diabetologia · doi:10.1007/s001250051618 · Cited by 103
Hypoglycemic Effect of Insulin-Transferrin Conjugate in Streptozotocin-Induced Diabetic Rats
Xia, C. Q., Wang, J., & Shen, W. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38943-8 · Cited by 103
Oral Delivery of Proteins: Progress and Prognostication
Shah, R. B., Ahsan, F., & Khan, M. A. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.20 · Cited by 100
Preparation and improvement of release behavior of chitosan microspheres containing insulin
Wang, L.-Y., Gu, Y., Su, Z. G., et al. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.033 · Cited by 100
Koevary, S. B. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489488 · Cited by 98
An enteric-coated dry emulsion formulation for oral insulin delivery
Toorisaka, E., Hashida, M., Kamiya, N., Ono, H., Kokazu, Y., & Goto, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.022 · Cited by 98
Sajeesh, S., & Sharma, C. P. (2005) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.30372 · Cited by 96
Yamagata, T., Morishita, M., Kavimandan, N. J., Nakamura, K., Fukuoka, Y., Takayama, K., & Peppas, N. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.005 · Cited by 94
Self-citationTerahara, T., Mitragotri, S., Kost, J., & Langer, R. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00981-4 · Cited by 94
Toorisaka, E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00674-9 · Cited by 92
Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels
Varshosaz, J., Sadrai, H., & Heidari, A. (2006) · Drug Delivery · doi:10.1080/10717540500309040 · Cited by 89
Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement
Yun, M. O. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00227-6 · Cited by 86
Quaglia, F., Rosa, G. D., Granata, E., Ungaro, F., Fattal, E., & Rotonda, M. I. L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00414-5 · Cited by 86
The colon as a site for drug delivery
Mrsny, R. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90113-6 · Cited by 86
Kissel, T., & Werner, U. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00253-8 · Cited by 85
Thiolated polymers: synthesis and in vitro evaluation of polymer–cysteamine conjugates
Bernkop‐Schnürch, A., Clausen, A. E., & Hnatyszyn, M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00807-9 · Cited by 84
The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals
Pettit, D. K., & Gombotz, W. R. (1998) · Trends in biotechnology · doi:10.1016/s0167-7799(98)01186-x · Cited by 84
Nasal delivery of insulin using chitosan microspheres
Varshosaz, J., Sadrai, H., & Alinagari, R. (2004) · Journal of Microencapsulation · doi:10.1080/02652040400015403 · Cited by 84
Recent Developments in Insulin Delivery Techniques
Kennedy, F. P. (1991) · Drugs · doi:10.2165/00003495-199142020-00004 · Cited by 83
Rosa, G. D., Larobina, D., Rotonda, M. I. L., Musto, P., Quaglia, F., & Ungaro, F. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.030 · Cited by 79
Transdermal iontophoresis revisited
Panchagnula, R., Pillai, O., Nair, V. B., & Ramarao, P. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00111-3 · Cited by 78
Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue
Kanikkannan, N., Singh, J., & Ramarao, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00184-9 · Cited by 78
The Colon as a Possible Target for Orally Administered Peptide and Protein Drugs
Rubinstein, A., & Haupt, S. M. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i6.10 · Cited by 77
Čilek, A., Çelebi, N., & Tırnaksız, F. (2006) · Drug Delivery · doi:10.1080/10717540500313109 · Cited by 76
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer
Değim, Z., Ünal, N., Eşsiz, D., et al. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.027 · Cited by 75
Dose Response of Inhaled Dry-Powder Insulin and Dose Equivalence to Subcutaneous Insulin Lispro
Rave, K., Nosek, L., de la Peña, A., Seger, M. E., Ernest, C. S., Heinemann, L., Batycky, R., & Muchmore, D. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2400 · Cited by 75
Phospholipid Deformable Vesicles for Buccal Delivery of Insulin.
Yang, T.-Z., Wang, X., Yan, X., & Zhang, Q. (2002) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.50.749 · Cited by 75
Evaluation of novel particles as pulmonary delivery systems for insulin in rats
Garcia‐Contreras, L., Morçöl, T., Bell, S. J. D., & Hickey, A. J. (2003) · AAPS PharmSci · doi:10.1208/ps050209 · Cited by 68
Aoki, Y., Morishita, M., Asai, K., Akikusa, B., Hosoda, S., & Takayama, K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6137-z · Cited by 67
Self-citationAbsorption and Metabolic Effect of Inhaled Insulin
Perera, A. D., Kapitza, C., Nosek, L., Fishman, R. S., Shapiro, D. A., Heise, T., & Heinemann, L. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2276 · Cited by 67
Hydrogels with Enhanced Mass Transfer for Transdermal Drug Delivery
Zhang, I., Shung, K. K., & Edwards, D. A. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601142 · Cited by 66
Transdermal Delivery of Insulin in Mice by Using Lecithin Vesicles as a Carrier
Guo, Q. P. J. (2000) · Drug Delivery · doi:10.1080/107175400266687 · Cited by 65
Liu, H., Tang, R., Pan, W., Zhang, Y., & Liu, H. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022052 · Cited by 65
Hosny, E. A., Al-Shora, H. I., & Elmazar, M. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00024-8 · Cited by 64
In Vivo Evaluation of a Nasal Insulin Delivery System Based on Thiolated Chitosan
Krauland, A. H., Leitner, V. M., Grabovac, V., & Bernkop‐Schnürch, A. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20700 · Cited by 64
Watnasirichaikul, S., Rades, T., Tucker, I. G., & Davies, N. M. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778736 · Cited by 64
Shao, Z., & Mitra, A. K. (1992) · Pharmaceutical Research · doi:10.1023/a:1015808023310 · Cited by 61
Defects generated in human stratum corneum specimens by ultrasound
Wu, J., Chappelow, J., Yang, J., et al. (1998) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(98)00049-0 · Cited by 61
Lipid emulsions as vehicles for enhanced nasal delivery of insulin
Mitra, R., Pezron, I., Chu, W. A., & Mitra, A. K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00506-8 · Cited by 59
Tozaki, H., Nishioka, J., Komoike, J., Okada, N., Fujita, T., Muranishi, S., Kim, S., Terashima, H., & Yamamoto, A. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200101)90:1<89::aid-jps10>3.0.co;2-a · Cited by 59
Effects of absorption promoters on insulin absorption through colon-targeted delivery
Katsuma, M., Watanabe, S., Kawai, H., Takemura, S., & Sako, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.028 · Cited by 58
Micromachined needle arrays for drug delivery or fluid extraction
Brazzle, J. D., Papautsky, I., & Frazier, A. B. (1999) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/51.805145 · Cited by 56
Bernkop‐Schnürch, A., & Scerbe-Saiko, A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011970703087 · Cited by 55
Agarwal, V., Reddy, I. K., & Khan, M. A. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00740-2 · Cited by 54
Synthesis and In Vitro Evaluation of Chitosan-Thioglycolic Acid Conjugates
Bernkop‐Schnürch, A., & Hopf, T. (2001) · Scientia Pharmaceutica · doi:10.3797/scipharm.aut-01-12 · Cited by 53
Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids
Mitra, R., Pezron, I., Li, Y., & Mitra, A. K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00588-9 · Cited by 51
BIOADHESIVE POLYMER SYSTEMS FOR PEPTIDE DELIVERY
Junginger, H. E. (1990) · Acta pharmaceutica technologica · Cited by 50
Joseph, J. W., Kalitsky, J., St-Pierre, S. A., & Brubaker, P. L. (2000) · Diabetologia · doi:10.1007/s001250051529 · Cited by 47
Transdermal Delivery of CaCO 3 -Nanoparticles Containing Insulin
Higaki, M., Kameyama, M., Udagawa, M., Ueno, Y., Yamaguchi, Y., Igarashi, R., Ishihara, T., & Mizushima, Y. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.369 · Cited by 45
Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning
Schipper, N. G. M., Verhoef, J., Romeijn, S. G., & Merkus, F. W. H. M. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90019-n · Cited by 44
Review on the systemic delivery of insulin via the ocular route
Lee, Y.-C., Simamora, P., Pinsuwan, S., & Yalkowsky, S. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00920-6 · Cited by 44
New Developments in Insulin Delivery
Ghilzai, N. M. K. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120018199 · Cited by 44
Influence of deposition and spray pattern of nasal powders on insulin bioavailability
Pringels, E., Callens, C., Vervaet, C., Dumont, F., Slegers, G., Foreman, P., & Remon, J. P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.049 · Cited by 43
McElduff, A., Mather, L. E., Kam, P. C. A., & Clauson, P. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02366.x · Cited by 42
Novel Mucosal Insulin Delivery Systems Based on Fusogenic Liposomes
Goto, T., Morishita, M., Nishimura, K., Nakanishi, M., Kato, A., Ehara, J., & Takayama, K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9175-7 · Cited by 42
Self-citationDouble Liposomes: Hypoglycemic Effects of Liposomal Insulin on Normal Rats
Katayama, K., Katō, Y., Onishi, H., Nagai, T., & Machida, Y. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120021771 · Cited by 40
Transdermal iontophoresis. Part I: Basic principles and considerations
Nair, V., Pillai, O., Poduri, R., et al. (1999) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.1999.21.2.529241 · Cited by 39
Transport studies of insulin across rat jejunum in the presence of chicken and duck ovomucoids
Agarwal, V., Nazzal, S., Reddy, I. K., & Khan, M. A. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776522 · Cited by 38
López, J. E., & Peppas, N. A. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120037480 · Cited by 38
Morishita, M., Aoki, Y., Sakagami, M., Nagai, T., & Takayama, K. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016244.88820.28 · Cited by 35
Self-citationAgarwal, V., Reddy, I. K., & Khan, M. A. (2000) · Pharmacy and Pharmacology Communications · doi:10.1211/146080800128735935 · Cited by 34
Xia, C. Q., & Shen, W. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032502097 · Cited by 33
New absorption promoter for the buccal delivery: Preparation and characterization of lysalbinic acid
Starokadomskyy, P., & Dubey, I. Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.013 · Cited by 31
Henry, R. R., Mudaliar, S. R. D., Chu, N. V., et al. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258657 · Cited by 29
Oral insulin delivery systems based on complexation polymer hydrogels
Morishita, M., Goto, T., Takayama, K., & Peppas, N. A. (2006) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(06)50003-6 · Cited by 27
Self-citationGranado, M., Martı́n, A. I., Priego, T., Villanúa, M. A., & López‐Calderón, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06585 · Cited by 26
Kapitza, C., Hompesch, M., Scharling, B., & Heise, T. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/1520915041705974 · Cited by 25
Morimoto, K., Uehara, Y., Iwanaga, K., & Kakemi, M. (2000) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(00)00024-8 · Cited by 25
Alkylglycosides enhance systemic absorption of insulin applied topically to the rat eye.
Pillion, D. J., Atchison, J. A., Wang, R., & Meezan, E. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24008-3 · Cited by 24
Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
Zhang, Y., Jiang, X., & Yao, J. (2001) · PubMed · Cited by 22
Biomembrane Permeability of Peptides: Strategies to Improve Their Mucosal Uptake
Bernkop‐Schnürch, A., & Clausen, A. E. (2002) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557023406007 · Cited by 20
Insulin Delivery Through the Ocular Route
Srinivasan, R., & Jain, S. K. (1998) · Drug Delivery · doi:10.3109/10717549809052027 · Cited by 19
Kondo, K., & Makita, T. (1997) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199704)247:4<455::aid-ar3>3.0.co;2-q · Cited by 16
Hypoglycemic efficacy of pulmonary delivered insulin dry powder aerosol in rats.
Chen, X., Zhu, J.-B., Wang, G., Zhou, M.-X., Xin, F.-M., Zhang, N., Wang, C., & Xu, Y.-N. (2002) · PubMed · Cited by 10
Cited by
Calvert, P. (2009) · Advanced Materials · doi:10.1002/adma.200800534 · Cited by 1,004
Magnetic nanocarriers: Evolution of spinel ferrites for medical applications
Amiri, M., Salavati-Niasari, M., & Akbari, A. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.01.003 · Cited by 651
Freiherr, J., Hallschmid, M., Frey, W. H., Brünner, Y. F., Chapman, C. D., Hölscher, C., Craft, S., De Felice, F. G., & Benedict, C. (2013) · CNS Drugs · doi:10.1007/s40263-013-0076-8 · Cited by 468
Chen, Y., Li, P., Modica, J. A., Drout, R. J., & Farha, O. K. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b02089 · Cited by 447
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
Chen, M.-C., Sonaje, K., Chen, K.-J., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.087 · Cited by 420
Metadata
- Authors
- Khafagy, E.-S., Morishita, M., Onuki, Y., & Takayama, K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 59
- Issue
- 15
- Pages
- 1521-1546
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1980439325
- Cited by
- 436
- References
- 200
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.